BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9012680)

  • 1. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):49-51. PubMed ID: 8643395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate C; Zapp ML; Green MR
    Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
    Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
    Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of oligonucleotide N3'-->P5' phosphoramidate/RNA duplexes with capillary gel electrophoresis.
    DeDionisio L; Raible AM; Gryaznov SM
    Electrophoresis; 1998 Jun; 19(8-9):1265-9. PubMed ID: 9694262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription.
    Darfeuille F; Arzumanov A; Gryaznov S; Gait MJ; Di Primo C; Toulmé JJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9709-14. PubMed ID: 12105271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR solution structure of the N3' --> P5' phosphoramidate duplex d(CGCGAATTCGCG)2 by the iterative relaxation matrix approach.
    Ding D; Gryaznov SM; Wilson WD
    Biochemistry; 1998 Sep; 37(35):12082-93. PubMed ID: 9724520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA and N3'-->P5' kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1.
    Darfeuille F; Cazenave C; Gryaznov S; Ducongé F; Di Primo C; Toulmé JJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):441-9. PubMed ID: 11563059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.